WO2009140327A2 - Rapport ara/epa équilibré dans des tissus de branchie et de rein de saumon pour améliorer une performance en eau de mer - Google Patents
Rapport ara/epa équilibré dans des tissus de branchie et de rein de saumon pour améliorer une performance en eau de mer Download PDFInfo
- Publication number
- WO2009140327A2 WO2009140327A2 PCT/US2009/043698 US2009043698W WO2009140327A2 WO 2009140327 A2 WO2009140327 A2 WO 2009140327A2 US 2009043698 W US2009043698 W US 2009043698W WO 2009140327 A2 WO2009140327 A2 WO 2009140327A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- ara
- smolt
- epa
- salmon
- feed
- Prior art date
Links
- 241000972773 Aulopiformes Species 0.000 title claims abstract description 49
- 235000019515 salmon Nutrition 0.000 title claims abstract description 49
- 239000013535 sea water Substances 0.000 title claims abstract description 38
- 210000005084 renal tissue Anatomy 0.000 title claims abstract description 14
- 238000012546 transfer Methods 0.000 claims abstract description 41
- 238000000034 method Methods 0.000 claims abstract description 29
- 239000000203 mixture Substances 0.000 claims description 24
- 235000019688 fish Nutrition 0.000 claims description 18
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 16
- 229930195729 fatty acid Natural products 0.000 claims description 16
- 239000000194 fatty acid Substances 0.000 claims description 16
- 150000004665 fatty acids Chemical class 0.000 claims description 16
- 210000002816 gill Anatomy 0.000 claims description 16
- 241000251468 Actinopterygii Species 0.000 claims description 15
- 150000003839 salts Chemical class 0.000 claims description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 14
- 108010004889 Heat-Shock Proteins Proteins 0.000 claims description 13
- 102000002812 Heat-Shock Proteins Human genes 0.000 claims description 13
- 150000002632 lipids Chemical class 0.000 claims description 8
- 235000019198 oils Nutrition 0.000 claims description 7
- 230000006978 adaptation Effects 0.000 claims description 6
- 235000021323 fish oil Nutrition 0.000 claims description 6
- 230000001965 increasing effect Effects 0.000 claims description 6
- 210000001519 tissue Anatomy 0.000 claims description 6
- 230000007704 transition Effects 0.000 claims description 6
- 239000002028 Biomass Substances 0.000 claims description 5
- 235000019733 Fish meal Nutrition 0.000 claims description 5
- 239000004467 fishmeal Substances 0.000 claims description 5
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 abstract description 120
- 229940114079 arachidonic acid Drugs 0.000 abstract description 60
- 235000021342 arachidonic acid Nutrition 0.000 abstract description 60
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 abstract description 41
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 abstract description 41
- 230000012010 growth Effects 0.000 abstract description 11
- 239000003921 oil Substances 0.000 abstract description 7
- 210000003734 kidney Anatomy 0.000 abstract description 2
- 229960005135 eicosapentaenoic acid Drugs 0.000 abstract 4
- 235000020673 eicosapentaenoic acid Nutrition 0.000 abstract 4
- 239000003674 animal food additive Substances 0.000 abstract 1
- 238000011084 recovery Methods 0.000 abstract 1
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 description 28
- 235000005911 diet Nutrition 0.000 description 26
- 230000037213 diet Effects 0.000 description 18
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 15
- 229940090949 docosahexaenoic acid Drugs 0.000 description 14
- 239000013505 freshwater Substances 0.000 description 12
- 230000035882 stress Effects 0.000 description 9
- 230000004083 survival effect Effects 0.000 description 9
- 230000000378 dietary effect Effects 0.000 description 8
- 241000277331 Salmonidae Species 0.000 description 7
- 235000000891 standard diet Nutrition 0.000 description 7
- 150000002066 eicosanoids Chemical class 0.000 description 6
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- 238000009360 aquaculture Methods 0.000 description 5
- 244000144974 aquaculture Species 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 4
- 241000277263 Salmo Species 0.000 description 4
- 235000020667 long-chain omega-3 fatty acid Nutrition 0.000 description 4
- 239000002243 precursor Substances 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 235000004626 essential fatty acids Nutrition 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 229960000890 hydrocortisone Drugs 0.000 description 3
- 230000006698 induction Effects 0.000 description 3
- 101100016370 Danio rerio hsp90a.1 gene Proteins 0.000 description 2
- 101100285708 Dictyostelium discoideum hspD gene Proteins 0.000 description 2
- 102100034051 Heat shock protein HSP 90-alpha Human genes 0.000 description 2
- 101001016865 Homo sapiens Heat shock protein HSP 90-alpha Proteins 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 101100071627 Schizosaccharomyces pombe (strain 972 / ATCC 24843) swo1 gene Proteins 0.000 description 2
- 241000269809 Sparus aurata Species 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 230000001934 delay Effects 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 229940013317 fish oils Drugs 0.000 description 2
- 230000000366 juvenile effect Effects 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 235000020660 omega-3 fatty acid Nutrition 0.000 description 2
- 230000008723 osmotic stress Effects 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- DVSZKTAMJJTWFG-SKCDLICFSA-N (2e,4e,6e,8e,10e,12e)-docosa-2,4,6,8,10,12-hexaenoic acid Chemical compound CCCCCCCCC\C=C\C=C\C=C\C=C\C=C\C=C\C(O)=O DVSZKTAMJJTWFG-SKCDLICFSA-N 0.000 description 1
- GZJLLYHBALOKEX-UHFFFAOYSA-N 6-Ketone, O18-Me-Ussuriedine Natural products CC=CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O GZJLLYHBALOKEX-UHFFFAOYSA-N 0.000 description 1
- 108091006112 ATPases Proteins 0.000 description 1
- 102000057290 Adenosine Triphosphatases Human genes 0.000 description 1
- 108091093088 Amplicon Proteins 0.000 description 1
- YZXBAPSDXZZRGB-DOFZRALJSA-M Arachidonate Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC([O-])=O YZXBAPSDXZZRGB-DOFZRALJSA-M 0.000 description 1
- XUIIKFGFIJCVMT-GFCCVEGCSA-N D-thyroxine Chemical compound IC1=CC(C[C@@H](N)C(O)=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-GFCCVEGCSA-N 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 102000018997 Growth Hormone Human genes 0.000 description 1
- 108010051696 Growth Hormone Proteins 0.000 description 1
- 101710113864 Heat shock protein 90 Proteins 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 102000005431 Molecular Chaperones Human genes 0.000 description 1
- 108010006519 Molecular Chaperones Proteins 0.000 description 1
- 241000277275 Oncorhynchus mykiss Species 0.000 description 1
- 241000157468 Reinhardtius hippoglossoides Species 0.000 description 1
- 241000277289 Salmo salar Species 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 229940114078 arachidonate Drugs 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 239000003181 biological factor Substances 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000005779 cell damage Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000010960 commercial process Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 208000022602 disease susceptibility Diseases 0.000 description 1
- KAUVQQXNCKESLC-UHFFFAOYSA-N docosahexaenoic acid (DHA) Natural products COC(=O)C(C)NOCC1=CC=CC=C1 KAUVQQXNCKESLC-UHFFFAOYSA-N 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 230000000459 effect on growth Effects 0.000 description 1
- 235000013345 egg yolk Nutrition 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000009313 farming Methods 0.000 description 1
- 230000006650 fundamental cellular process Effects 0.000 description 1
- 239000000122 growth hormone Substances 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 230000012447 hatching Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000013632 homeostatic process Effects 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000004941 influx Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000037427 ion transport Effects 0.000 description 1
- 230000001418 larval effect Effects 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 150000004668 long chain fatty acids Chemical class 0.000 description 1
- 238000007726 management method Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000037353 metabolic pathway Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000013586 microbial product Substances 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 210000000663 muscle cell Anatomy 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 235000018343 nutrient deficiency Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000020665 omega-6 fatty acid Nutrition 0.000 description 1
- 229940033080 omega-6 fatty acid Drugs 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 210000004279 orbit Anatomy 0.000 description 1
- 230000000426 osmoregulatory effect Effects 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000000384 rearing effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 102000037983 regulatory factors Human genes 0.000 description 1
- 108091008025 regulatory factors Proteins 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000003938 response to stress Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000003757 reverse transcription PCR Methods 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000037351 starvation Effects 0.000 description 1
- 239000003270 steroid hormone Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229940034208 thyroxine Drugs 0.000 description 1
- XUIIKFGFIJCVMT-UHFFFAOYSA-N thyroxine-binding globulin Natural products IC1=CC(CC([NH3+])C([O-])=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-UHFFFAOYSA-N 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/80—Feeding-stuffs specially adapted for particular animals for aquatic animals, e.g. fish, crustaceans or molluscs
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K61/00—Culture of aquatic animals
- A01K61/80—Feeding devices
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/20—Animal feeding-stuffs from material of animal origin
- A23K10/22—Animal feeding-stuffs from material of animal origin from fish
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/158—Fatty acids; Fats; Products containing oils or fats
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
- Y02A40/80—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in fisheries management
- Y02A40/81—Aquaculture, e.g. of fish
Definitions
- the present invention relates to salmon smolt feeding, and more specifically, to the enhancement of growth performance of the salmon smolt when transferring from fresh water hatcheries to salt water environment by introducing a feeding regime with increased levels of arachidonic acid (ARA) prior to such sea water transfer to increase the ratio of ARA to eicosapentanoic acid (EPA) to at least 0.9 in gill and/or kidney tissue of the salmon smolt at the stage of sea water transfer.
- ARA arachidonic acid
- EPA eicosapentanoic acid
- a critical stage of current salmon farming practice is the transfer of smolts from freshwater hatcheries to ocean net pens when they have attained a critical size of approximately 70-110 grams body weight (for reviews see: (Eddy 1981; Bley and Moring 1988; Bakke, Bjerknes et al. 1991; Jonsson, Hansen et al. 1993).
- the newly placed smolt in the ocean net pens do not grow optimally during their first 40-60 day interval in seawater because of the presence of osmotic stress that delays their feeding (Salminen, Erkamo et al. 2001).
- HSPs Heat shock proteins
- the present invention provides for farmed raised salmon smolt using standard aquaculture practices and further defined by a specific fatty acid composition of the gills of the raised salmon smolt that comprise an ARA/EPA ratio of greater than 0.9 and that subsequently grow faster and are more resistant to stress associated with the transfer from fresh to sea water.
- One aspect of the present invention provides for a method of feeding farm raised salmon smolt and/or parr to prepare same for the transition from a fresh to salt water habitat, the method comprising: providing a smolt/parr feed composition comprising ARA and EPA wherein the ratio of ARA to EPA is at least 0.2; and administering the feed composition to the smolt/parr for at least 7 weeks prior to the transfer from fresh to sea water habitat, and more preferably from about 10 to 15 weeks prior to such transfer thereby providing for smolt salmon having an ARA/EPA ratio of greater than 0.9 in gill and/or kidney tissue at the time of transfer.
- Such feed may comprise conventional ingredients well known to those with experience in salmon aquaculture and preferably contain ARA at levels of from 2% to 5% of total fatty acids while maintaining EPA levels from 5% to 10% of total fatty acids.
- the feed composition may comprises, fish meal, fish oil lipid components, and/or microalgal oil or microalgal biomass containing long chain fatty acids such as ARA, EPA and DHA. Further, the feed comprises a DHA/EPA ratio of greater than 0.5.
- Another aspect of the present invention provides for a feed wherein the proportion between ARA and EPA in the lipids is sufficient to increase the ARA proportion in gill and kidney tissues of smolt to at least a level that matches the levels of EPA.
- Yet another aspect of the present invention provides for a method to increase levels of heat shock proteins for enhanced adaptation of hyperosmotic stress in smolt salmon after transfer from fresh to salt water habitat, the method comprising: providing a smolt/parr feed composition wherein the feed composition comprises ARA and EPA and wherein the ratio of ARA to EPA is at least 0.2, and more preferably a ratio of at least 0.5 to 2; and administering the feed composition to the smolt/parr for at least 7 weeks prior to the transfer from fresh to sea water habitat, and more preferably from about 10 to 15 weeks prior to such transfer thereby providing for smolt having at least twice the levels of heat shock proteins relative to smolt consuming a feed lacking a ratio of ARA to EPA of at least 0.2.
- a still further aspect of the present invention relates to a method of feeding smolt salmon before transfer of the smolt salmon from fresh to salt water habitat, the method comprising: providing smolt salmon having a fish weight of about 30 g; feeding the smolt salmon a feed containing a balanced proportion of ARA/EPA of at least 0.2 for at least 4 weeks prior to the transfer of from fresh to salt water habitat or until the smolt salmon reaches the weight of 100 g.
- the transferred smolt salmon are fed the feed containing a balanced proportion of ARA/EPA of at least 0.2 for additional 30 days after the sea water transfer.
- Another aspect of the present invention relates to a smolt salmon having a weight of approximately 80 to 110 grams and having an ARA/EPA ratio of greater than 0.9 in gill and/or kidney tissue.
- the gill and/or kidney tissue is tested for an ARA/EPA ratio level greater than 0.9 in the 10 day period before transfer from the fresh to salt water environment.
- Yet another aspect relates to a feed comprising fish meal or fish oil substantially balanced by the addition of ARA.
- the term “smolt” is used to describe a salmon fingerling that is cultured in fresh water and is about to transfer to seawater.
- the term "parr” is used to describe a salmon fingerling that is undergoing physiological changes that result in visible morphological and behavior changes known as smoltification.
- Salmon aquaculture typically involves the raising of salmon fry in freshwater followed by their transfer to sea water where they are grown to a commercial size on diets containing predominantly fish meal and fish oil. During the freshwater to sea water transition (i.e., smoltification), the fish are under a high degree of stress and grow poorly and are susceptible to disease.
- Tissues of the salmon have an osmolality of about 5-7 parts per thousand (ppt).
- ppt parts per thousand
- salmon eggs are hatched in fresh water (ca. 2-4 ppt) and the salmon fry matures into a parr that then must go through the smoltification process of gradual increases in salinity up to full strength seawater (ca. 25-28 ppt) prior to stocking seawater pens for the grow-out phase of the commercial process. This transition period is very stressful on the fish and results in reduced growth rates and increases in disease susceptibility.
- Conventional salmon aquaculture feeds are rich in fish oil (ca. up to 25% by weight) which itself is rich in EPA.
- the present invention has shown that surprisingly the addition of a certain long chain omega-6 lipid, that being ARA, to the diet of pre-smolt fish allows these animals to pass through this process with a minimal impact on growth and disease sensitivity.
- the net result is a significant improvement of growth and shortening the time to reach market size.
- Such an invention can significantly improve the economics of commercial salmon production.
- ARA can be produced by the elongation and desaturation of omega-6 fatty acid precursors such as linoleic acid.
- EPA can be produced by the elongation and desaturation of omega-3 precursors such as linolenic acid.
- omega-6 precursors to ARA is antagonized by long chain omega-3 fatty acids, such as EPA and its eicosanoid derivatives (Bell, Castell et al. 1995).
- the enzymatic conversion of omega-3 precursors to EPA is antagonized by ARA and its eicosanoid derivatives.
- DHA long chain omega-3 fatty acids
- Sources of ARA and its esters may include ARA-containing microbial oils or biomass (Barclay 2008), ARA containing algal oils or biomass (Kyle 2005). ARA extracts from animal byproducts such as brain or liver (Abril and Wills 2008), ARA from recombinant plants or microbes (Chen 2008) or ARA from egg yolk. Sources or DHA and its esters that have minimal levels of EPA and its esters include micoralgal oils and their biomass (Bailey, Dimasi et al. 2008), recombinant microbial products (Chen 2008; Metz, Weaver et al.
- Example 1 Preparation of salmon smolt feed containing ARA/EPA ratio of at least 0.2.
- a standard commercial diet for smolt (commercially available as starter feed from Ziegler Bros, PA with 2 and 3 mm pellets) was analyzed for its EPA content. Then the same starter feed was enhanced according to the methods of the present invention by top coating the pellets with ARA oil (40% ARA, Martek BioSci. Columbia, MD) to adjust the ARA/EPA ratio in the diet to at least 0.2.
- Table 1 provides the fatty acid composition (% of total fatty acids) of a standard commercial diet and diet of the present invention.
- Example 2 Feeding schedule of salmon smolt the feed of the present invention.
- Each diet was assigned to two tanks containing 120 fish in each starting average size of 30 g. Smoltification was induced when the fish reached an average weight of 85g. Fish were then transferred to sea water and continue feeding for additional 4 weeks.
- Table 2 shows the ARA and EPA levels in salmon smolt at the stage of sea water transfer that fed standard diet or diet of the present invention.
- Example 3 Growth of salmon smolt fed the diet of the present invention in sea water.
- qRT-PCR Quantitative Reverse Transcription Polymerase Chain Reaction
- Salminen, M., E. Erkamo, et al. (2001). "Diet of post-smolt and one-sea-winter Atlantic salmon, in the Bothnian Sea, Northern Baltic.” Journal of Fish Biology 58: 16-35.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Polymers & Plastics (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Animal Husbandry (AREA)
- Marine Sciences & Fisheries (AREA)
- Food Science & Technology (AREA)
- Environmental Sciences (AREA)
- Biotechnology (AREA)
- Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Insects & Arthropods (AREA)
- Birds (AREA)
- Biodiversity & Conservation Biology (AREA)
- Physiology (AREA)
- Fodder In General (AREA)
- Farming Of Fish And Shellfish (AREA)
- Feed For Specific Animals (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Meat, Egg Or Seafood Products (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
La présente invention porte sur un saumoneau comprenant un rapport acide arachidonique (ARA) sur acide eicosapentaénoïque (EPA) d'un ou plus, spécifiquement dans des tissus de branchie et de rein. L'invention porte sur un additif alimentaire contenant ARA et sur son utilisation dans une quantité suffisante pour équilibrer la quantité en excès de EPA provenant des huiles marines utilisées dans l'alimentation standard pour saumon. L'invention porte également sur un procédé pour moduler le rapport ARA/EPA de branchie et de rein en faveur de ARA. Un saumoneau de la présente invention démontre une récupération de croissance supérieure et une résistance au stress supérieure après leur transfert en eau de mer.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP09747411A EP2293688A4 (fr) | 2008-05-13 | 2009-05-13 | Rapport ara/epa équilibré dans des tissus de branchie et de rein de saumon pour améliorer une performance en eau de mer |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US5280208P | 2008-05-13 | 2008-05-13 | |
US61/052,802 | 2008-05-13 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2009140327A2 true WO2009140327A2 (fr) | 2009-11-19 |
WO2009140327A3 WO2009140327A3 (fr) | 2010-03-11 |
Family
ID=41319302
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2009/043698 WO2009140327A2 (fr) | 2008-05-13 | 2009-05-13 | Rapport ara/epa équilibré dans des tissus de branchie et de rein de saumon pour améliorer une performance en eau de mer |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP2293688A4 (fr) |
CL (1) | CL2009001164A1 (fr) |
WO (1) | WO2009140327A2 (fr) |
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012021703A1 (fr) * | 2010-08-11 | 2012-02-16 | E. I. Du Pont De Nemours And Company | Stratégie d'alimentation durable utilisable en aquaculture |
WO2012021686A1 (fr) * | 2010-08-11 | 2012-02-16 | E. I. Du Pont De Nemours And Company | Produits améliorés à base de chair d'animaux d'aquaculture |
US8968721B2 (en) | 2005-12-28 | 2015-03-03 | Advanced Bionutrition Corporation | Delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same |
US9044497B2 (en) | 2005-12-28 | 2015-06-02 | Advanced Bionutrition Corporation | Delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same |
US9072310B2 (en) | 2006-12-18 | 2015-07-07 | Advanced Bionutrition Corporation | Dry food product containing live probiotic |
EP3075261A1 (fr) | 2015-03-31 | 2016-10-05 | Universidad De Santiago De Chile | Formulation d'un complément alimentaire d'un extrait d'hypericum perforatum et rosmarinus officinalis (ro) ou d'un mélange des deux, qui améliore les barrières d'antioxydants endogènes, augmente le gain de poids dans l'élevage de poissons, et prolonge la durée de vie des poissons d'élevage affectés par des événements stressants et réduit une infection pathogène |
US9504750B2 (en) | 2010-01-28 | 2016-11-29 | Advanced Bionutrition Corporation | Stabilizing composition for biological materials |
US9504275B2 (en) | 2010-08-13 | 2016-11-29 | Advanced Bionutrition Corporation | Dry storage stabilizing composition for biological materials |
US9623094B2 (en) | 2009-03-27 | 2017-04-18 | Advanced Bionutrition Corporation | Microparticulated vaccines for the oral or nasal vaccination and boostering of animals including fish |
US9731020B2 (en) | 2010-01-28 | 2017-08-15 | Advanced Bionutrition Corp. | Dry glassy composition comprising a bioactive material |
WO2019048776A1 (fr) * | 2017-09-06 | 2019-03-14 | Ynsect | Poudre d'insectes pour prevenir ou reduire le stress des poissons pendant l'elevage |
US10953050B2 (en) | 2015-07-29 | 2021-03-23 | Advanced Bionutrition Corp. | Stable dry probiotic compositions for special dietary uses |
US11214597B2 (en) | 2009-05-26 | 2022-01-04 | Advanced Bionutrition Corp. | Stable dry powder composition comprising biologically active microorganisms and/or bioactive materials and methods of making |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2664452B2 (ja) * | 1988-12-23 | 1997-10-15 | サントリー株式会社 | 魚貝類用餌料 |
EP1087669B2 (fr) * | 1998-06-17 | 2010-09-22 | DSM IP Assets B.V. | Composition pour l'alimentation d'animaux marins comprenant de l'acide arachidonique microbien |
CA2424570A1 (fr) * | 2000-09-07 | 2002-03-14 | University Of Maryland Biotechnology Institute | Utilisation de l'acide arachidonique pour renforcer l'elevage des larves de poissons et le stock de reproducteurs |
GB0300602D0 (en) * | 2003-01-10 | 2003-02-12 | Forinnova As | Compositions |
EP1619960A4 (fr) * | 2003-03-07 | 2009-03-18 | Advanced Bionutrition Corp | Preparation d'aliments pour animaux terrestres et aquatiques |
GB0417977D0 (en) * | 2004-08-12 | 2004-09-15 | Seabait Ltd | "Enhanced aquaculture feeds" |
-
2009
- 2009-05-13 WO PCT/US2009/043698 patent/WO2009140327A2/fr active Application Filing
- 2009-05-13 CL CL2009001164A patent/CL2009001164A1/es unknown
- 2009-05-13 EP EP09747411A patent/EP2293688A4/fr not_active Withdrawn
Non-Patent Citations (1)
Title |
---|
See references of EP2293688A4 * |
Cited By (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9044497B2 (en) | 2005-12-28 | 2015-06-02 | Advanced Bionutrition Corporation | Delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same |
US9737578B2 (en) | 2005-12-28 | 2017-08-22 | Advanced Bionutrition Corp. | Delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same |
US8968721B2 (en) | 2005-12-28 | 2015-03-03 | Advanced Bionutrition Corporation | Delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same |
US9480276B2 (en) | 2006-12-18 | 2016-11-01 | Advanced Bionutrition Corporation | Dry food product containing live probiotic |
US9072310B2 (en) | 2006-12-18 | 2015-07-07 | Advanced Bionutrition Corporation | Dry food product containing live probiotic |
US9623094B2 (en) | 2009-03-27 | 2017-04-18 | Advanced Bionutrition Corporation | Microparticulated vaccines for the oral or nasal vaccination and boostering of animals including fish |
US11214597B2 (en) | 2009-05-26 | 2022-01-04 | Advanced Bionutrition Corp. | Stable dry powder composition comprising biologically active microorganisms and/or bioactive materials and methods of making |
US10575545B2 (en) | 2010-01-28 | 2020-03-03 | Advanced Bionutrition Corp. | Stabilizing composition for biological materials |
US9504750B2 (en) | 2010-01-28 | 2016-11-29 | Advanced Bionutrition Corporation | Stabilizing composition for biological materials |
US9731020B2 (en) | 2010-01-28 | 2017-08-15 | Advanced Bionutrition Corp. | Dry glassy composition comprising a bioactive material |
US10206421B2 (en) | 2010-01-28 | 2019-02-19 | Advanced Bionutrition Corp. | Stabilizing composition for biological materials |
WO2012021703A1 (fr) * | 2010-08-11 | 2012-02-16 | E. I. Du Pont De Nemours And Company | Stratégie d'alimentation durable utilisable en aquaculture |
WO2012021686A1 (fr) * | 2010-08-11 | 2012-02-16 | E. I. Du Pont De Nemours And Company | Produits améliorés à base de chair d'animaux d'aquaculture |
US9504275B2 (en) | 2010-08-13 | 2016-11-29 | Advanced Bionutrition Corporation | Dry storage stabilizing composition for biological materials |
EP3075261A1 (fr) | 2015-03-31 | 2016-10-05 | Universidad De Santiago De Chile | Formulation d'un complément alimentaire d'un extrait d'hypericum perforatum et rosmarinus officinalis (ro) ou d'un mélange des deux, qui améliore les barrières d'antioxydants endogènes, augmente le gain de poids dans l'élevage de poissons, et prolonge la durée de vie des poissons d'élevage affectés par des événements stressants et réduit une infection pathogène |
US10953050B2 (en) | 2015-07-29 | 2021-03-23 | Advanced Bionutrition Corp. | Stable dry probiotic compositions for special dietary uses |
JP2020532308A (ja) * | 2017-09-06 | 2020-11-12 | インセクト | 飼育下の魚類のストレスを防止又は減少するための昆虫粉末 |
WO2019048776A1 (fr) * | 2017-09-06 | 2019-03-14 | Ynsect | Poudre d'insectes pour prevenir ou reduire le stress des poissons pendant l'elevage |
US11432567B2 (en) | 2017-09-06 | 2022-09-06 | Ynsect | Insect powder for the prevention or reduction of stress in fish during rearing |
JP7293200B2 (ja) | 2017-09-06 | 2023-06-19 | インセクト | 飼育下の魚類のストレスを防止又は減少するための昆虫粉末 |
Also Published As
Publication number | Publication date |
---|---|
EP2293688A2 (fr) | 2011-03-16 |
EP2293688A4 (fr) | 2011-05-25 |
CL2009001164A1 (es) | 2010-04-09 |
WO2009140327A3 (fr) | 2010-03-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2293688A2 (fr) | Rapport ara/epa équilibré dans des tissus de branchie et de rein de saumon pour améliorer une performance en eau de mer | |
Morais et al. | New developments and biological insights into the farming of Solea senegalensis reinforcing its aquaculture potential | |
Harel et al. | Advanced DHA, EPA and ArA enrichment materials for marine aquaculture using single cell heterotrophs | |
Sorgeloos et al. | Use of the brine shrimp, Artemia spp., in marine fish larviculture | |
Nanton et al. | The effects of temperature and dietary fatty acids on the fatty acid composition of harpacticoid copepods, for use as a live food for marine fish larvae | |
Norambuena et al. | Towards the optimization of performance of Atlantic salmon reared at different water temperatures via the manipulation of dietary ARA/EPA ratio | |
Carrier III et al. | Effects of dietary arachidonic acid on larval performance, fatty acid profiles, stress resistance, and expression of Na+/K+ ATPase mRNA in black sea bass Centropristis striata | |
Zhou et al. | Effects of dietary lipids on tissue fatty acids profile, growth and reproductive performance of female rice field eel (Monopterus albus) | |
Betancor et al. | Lipid metabolism-related gene expression pattern of Atlantic bluefin tuna (Thunnus thynnus L.) larvae fed on live prey | |
Domaizon et al. | Influence of zooplankton and phytoplankton on the fatty acid composition of digesta and tissue lipids of silver carp: mesocosm experiment | |
JP2020103312A (ja) | 水産養殖試料における使用のための試料添加材料 | |
Mourente et al. | Tuna nutrition and feeds: current status and future perspectives | |
Xu et al. | Polyunsaturated fatty acid supplements could considerably promote the breeding performance of carp | |
Watanabe et al. | Live prey enrichment and artificial microdiets for larviculture of Atlantic red porgy Pagrus pagrus | |
Hossain et al. | Insect lipid in fish nutrition: Recent knowledge and future application in aquaculture | |
Yılmaz et al. | Effects of fish oil substitution with two different vegetable oil classes on fatty acid digestibility in juvenile European Sea Bass, Dicentrarchus labrax | |
Pan et al. | Impacts of different feeding modes on the gonadal development, total edible yield, and nutritional composition of male Chinese mitten crab (Eriocheir sinensis) | |
Serrano et al. | Partially replacing fish oil with microalgae (Schizochytrium limacinum and Nannochloropsis oceanica) in diets for rainbow trout (Oncorhynchus mykiss) reared in saltwater with reference to growth performance, muscle fatty acid composition and liver ultrastructure | |
Gladyshev | Terrestrial sources of polyunsaturated fatty acids for aquaculture | |
Mráz | Lipids in common carp (Cyprinus carpio) and effects on human health | |
Khan et al. | Supplemental effect of Porphyra spheroplasts on the growth and feed utilization of black sea bream | |
Immanuel et al. | Feeding trashfish Odonus niger lipid enriched Artemia nauplii on growth, stress resistance and HUFA requirements of Penaeus monodon postlarvae | |
Kaçar | n-3 and N-6 Fatty Acids in Fish: A Focus on Non-Marine Species | |
El-Sayed et al. | Evaluation of short and long term enrichment of Artemia franciscana with mixed algae or DHA oil emulsion for improving Dicentrarchus labrax larvae aquaculture | |
Hossen et al. | Performance of different dietary lipids on growth indices and survival of striped gourami, Colisa fasciatus(Perciformes: Osphronemidae) fry |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 09747411 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2009747411 Country of ref document: EP |